AVTX icon

Avalo Therapeutics

64 hedge funds and large institutions have $223M invested in Avalo Therapeutics in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more ownership

Funds ownership: 0.02%0.02% (+0%)

27% less call options, than puts

Call options by funds: $264K | Put options by funds: $362K

Holders
64
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$264K
Puts
$362K
Net Calls
Net Calls Change

Top Buyers

1 +$21.1M
2 +$5.18M
3 +$4.18M
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$2.68M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.67M

Top Sellers

1 -$4.34M
2 -$3.75M
3 -$3.38M
4
SCM
Sio Capital Management
New York
-$1.67M
5
Renaissance Technologies
Renaissance Technologies
New York
-$860K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$33K
52
$30.4K
53
$22K
54
$18K
55
$18K
56
$16K
57
$12K
58
$10K
59
$10K
60
$9.75K
61
$8K
62
$6K
63
$2K
64
$2K
65
$1K
66
$97
67
$10
68
69
70
71
72
73
74
75